Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma

Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospectiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2022-11, Vol.44 (11), p.2491-2504
Hauptverfasser: Miller, Jacob A., Moradi, Farshad, Sundaram, Vandana, Liang, Rachel, Zhang, Carrie, Nguyen, Ngan Kim, Akhtar, Faisal, Liu, Yuhan, Ren, Yulan, Harandi, Nima, Weng, Yingjie, Pollom, Erqi L., Colevas, Alexander Dimitrios, Divi, Vasu, Holsinger, Floyd Christopher, Beadle, Beth M., Le, Quynh‐Thu, Gensheimer, Michael F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospective cohort study of patients with node‐positive OPSCC treated with definitive (chemo)radiotherapy. We assessed Hopkins Criteria performance for LRR, then developed and validated a competing‐risks model. Results Between 2004 and 2018, 259 patients were included with median follow‐up of 43 months. The Hopkins Criteria sensitivity, specificity, negative predictive value, and accuracy were 68%, 88%, 95%, and 85%. The 36‐month cumulative incidence of LRR was greater with positive scores (45% vs. 5%, HR 12.60, p 
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.27160